BIOCEPT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | +9,900.00% |
|
0.00% | -99.76% |
| Apr. 02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
| 2023 | Biocept, Inc.(OTCPK:BIOC.Q) dropped from NASDAQ Composite Index | CI |
Chart calendar Biocept, Inc.
449.YrarHfWIlnoABDspy-Mp0Yb8n-lXU929UEW0Ye_azZo.K9GYfp3s7ytlb2pKodFInOGf2aM7Nq73aRraVLW3vfMM18F2lNH5FXZ1eg~28de959bcf1a6586a660ceca3b73526e
Upcoming events on Biocept, Inc.
Past events on Biocept, Inc.
| 2024-03-26 | Q4 2023 Earnings Release (Projected) |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-30 04:00 pm | Business Update Call |
| 2023-08-14 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-20 09:00 am | Maxim Group Virtual Healthcare Conference |
| 2023-04-17 04:10 pm | Q4 2022 Earnings Release |
| 2022-11-28 04:00 pm | Q3 2022 Earnings Call |
| 2022-11-21 04:05 pm | Q3 2022 Earnings Release |
| 2022-11-10 04:05 pm | Interim 2022 Earnings Release |
| 2022-10-26 05:30 pm | LD Micro Main Event Conference |
| 2022-10-14 01:00 pm | Investor Meeting - Key Opinion Leader |
| 2022-06-07 04:00 pm | Business Update Call |
| 2022-05-10 | Q1 2022 Earnings Release (Projected) |
| 2022-04-06 08:00 am | FY 2021 Earnings Release |
| 2022-01-10 07:00 am | H.C. Wainwright BioConnect Conference |
| 2021-12-07 | San Antonio Breast Cancer Symposium |
| 2021-11-19 07:30 pm | Society for Neuro-Oncology Meeting |
| 2021-11-15 04:30 pm | Q3 2021 Earnings Call |
| 2021-11-15 04:05 pm | Q3 2021 Earnings Release |
| 2021-10-13 02:00 pm | LD Micro Main Event Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,25 3,28 -0.78% | 5,53 5,44 1.55% | 27,5 21,2 29.39% | 61,2 58,4 4.85% | 25,9 39,4 -34.38% |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -24,3 -24,3 0.06% | -23,1 -22,2 -3.79% | -15,5 -20,6 24.78% | -2,41 -1,44 -66.87% | -32,0 -17,6 -82.22% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,6 -24,5 -0.25% | -25,1 -24,2 -3.74% | -17,8 -22,8 22.03% | -2,70 -1,70 -58.59% | -32,2 -17,8 -80.78% |
|
Net income Million USD | Released Forecast Spread | -25,2 -25,1 -0.25% | -25,3 -24,3 -3.81% | -17,8 -22,8 22% | -2,82 -1,70 -65.93% | -32,1 -17,8 -80.08% |
|
EPS USD | Released Forecast Spread | -2 703 -2 856 5.36% | -366 -288 -27.08% | -45,0 -63,3 28.91% | -5,70 -3,60 -58.33% | -56,7 -31,4 -80.86% |
| Announcement Date | 28/03/19 | 25/03/20 | 29/03/21 | 06/04/22 | 17/04/23 |
Quarterly results
| Fiscal Period | December | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 12,0 9,74 23.69% | 17,5 16,1 8.82% | 13,9 11,1 25.49% | 19,9 11,5 73.58% | 10,6 12,5 -14.93% | 5,59 7,86 -28.92% | -10,3 3,27 -414.96% | 0,67 1,58 -57.46% | 0,59 1,65 -64.3% |
|
EBIT Million USD | Released Forecast Spread | -1,75 -2,27 23.11% | 0,50 0,96 -47.81% | -2,78 -2,86 3% | -2,71 -4,01 32.53% | -5,10 -2,65 -92.09% | -5,58 -5,32 -4.87% | -18,6 -4,17 -346.01% | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,83 -2,27 19.6% | 0,43 0,92 -53.54% | -2,85 -2,90 1.89% | -2,77 -4,09 32.36% | -5,25 -2,70 -94.81% | -5,55 -5,32 -4.27% | -18,6 -4,21 -342.82% | ||
|
Net income Million USD | Released Forecast Spread | -1,83 -2,27 19.6% | 0,43 0,92 -53.54% | -2,97 -2,90 -2.42% | -2,77 -4,09 32.36% | -5,25 -2,70 -94.81% | -5,55 -5,32 -4.27% | -18,5 -4,21 -339.85% | ||
|
EPS USD | Released Forecast Spread | -15,3 -4,80 -218.75% | 0,90 1,95 -53.85% | -5,40 -5,70 5.26% | -4,80 -7,20 33.33% | -9,30 -4,80 -93.75% | -9,90 -9,30 -6.45% | -32,7 -7,35 -344.9% | ||
| Announcement Date | 16/08/21 | 15/11/21 | 06/04/22 | 23/05/22 | 10/11/22 | 21/11/22 | 17/04/23 | 10/05/23 | 14/08/23 |
More events
Past sector events for Biocept, Inc.
| Today 02:00 am | VITROLIFE AB: Q1 2024 Earnings Release |
| 2024-04-15 | AMOY DIAGNOSTICS CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-11 | SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-09 01:00 am | BIOMÉRIEUX: Q1 2024 Sales and Revenue Release |
| 2024-03-29 | BEIJING STRONG BIOTECHNOLOGIES,INC.: Q4 2023 Earnings Release |
| 2024-03-27 | NEW HORIZON HEALTH LIMITED: Q4 2023 Earnings Release |
| 2024-03-27 02:30 am | SD BIOSENSOR, INC: Q4 2023 Earnings Release |
| 2024-03-22 | SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD: Q4 2023 Earnings Release |
| 2024-03-21 | SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-15 08:35 am | DIASORIN S.P.A.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIOCQ Stock
- Calendar Biocept, Inc.
